Graf Akcie AVEO (AVEO Pharmaceuticals Inc). Diskuze k akciím AVEO. Aktuální informace AVEO.

Základní informace o společnosti AVEO Pharmaceuticals Inc (Akcie AVEO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 219.65M
Hodnota podniku (EV) 157.02M
Tržby 13.962M
EBITDA -54.89
Zisk -55.62
Růst v tržbách Q/Q 908.81 %
Růst v tržbách Y/Y -50.16 %
P/E (Cena vůči ziskům) N/A
Forward P/E -3.93
EV/Sales 11.25
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 15.73
P/FCF N/A
Price/Book 6.22
Účetní hodnota na akcii 1.03
Hotovost na akcii 1.79
FCF vůči ceně -25.51 %
Počet zaměstnanců 94
Tržba na zaměstnance 148.532k
Profit margin -591.19 %
Operating margin -393.46 %
Gross margin 100.00 %
EBIT margin -379.14 %
EBITDA margin -393.10 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -4.76 %
EPS - Očekávaný růst příští rok 9.09 %
Return on assets -58.49 %
Return on equity -106.87 %
ROIC -57.83 %
ROCE -55.43 %
Dluhy/Equity 0.90
Čistý dluh/EBITDA 4.73
Current ratio 6.39
Quick Ratio 6.39
Volatilita 4.41
Beta 1.08
RSI 49.76
Cílová cena analytiků 11
Známka akcie (dle analytiků) 1.25
Insider ownership 0.12 %
Institutional ownership 42.87 %
Počet akcií 34.374M
Procento shortovaných akcií 6.33 %
Short ratio 5.03 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2010
Země United States

Finanční výsledky akcie AVEO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$28.795$5.409$7.579$2.515$19.024$18.123
Cost Of Goods Sold------
Gross Profit$28.795$5.409$7.579$2.515$19.024$18.123
Research And Development Expenses$17.958$20.652$25.179$23.703$12.875$38.254
SG&A Expenses$11.211$10.781$9.138$8.205$10.217$18.589
Other Operating Income Or Expenses-$0.667$-2.073-$-4-
Operating Expenses$29.169$30.766$36.39$31.908$31.45$68.572
Operating Income$-0.374$-25.357$-28.811$-29.393$-12.426$-50.449
Total Non-Operating Income/Expense$9.762$20.028$-36.113$2.607$-2.575$-2.29
Pre-Tax Income$9.388$-5.329$-64.924$-26.786$-15.001$-52.739
Income Taxes--$0.101$0.101--
Income After Taxes$9.388$-5.329$-65.025$-26.887$-15.001$-52.739
Other Income------
Income From Continuous Operations$9.388$-5.329$-65.025$-26.887$-15.001$-52.739
Income From Discontinued Operations------
Net Income$9.388$-25.248$-65.025$-26.887$-15.001$-52.739
EBITDA$-0.418$-25.354$-28.743$-29.349$-2.825$-44.009
EBIT$-0.374$-25.357$-28.811$-29.393$-12.426$-50.449
Basic Shares Outstanding151211765
Shares Outstanding151311765
Basic EPS$0.61$-0.44$-6.14$-3.90$-2.70$-10.10
EPS - Earnings Per Share$0.61$-1.93$-6.14$-3.90$-2.70$-10.10
# 2020 2019 2018 2017 2016 2015
Current Ratio2.39611.54191.56222.54283.25671.4652
Long-term Debt / Capital0.2945-1.3783-0.82911.19320.3010.3023
Debt/Equity Ratio1.062-0.699-0.4533-7.28190.54981.0022
Gross Margin100100100100100100
Operating Margin-1.2988-468.7928-380.1425-1168.708-65.3175-278.3701
EBIT Margin-1.2988-468.7928-380.1425-1168.708-65.3175-278.3701
EBITDA Margin-1.4516-468.7373-379.2453-1166.958-14.8497-242.8351
Pre-Tax Profit Margin32.6029-98.521-856.6302-1065.05-78.853-291.0059
Net Profit Margin32.6029-466.7776-857.9628-1069.066-78.853-291.0059
Asset Turnover0.56910.19360.1510.09220.46920.2565
Inventory Turnover Ratio------
Receiveable Turnover17.65481.78750.49212.44894.09917.7416
Days Sales In Receivables20.6743204.1949741.7509149.047789.043647.1481
ROE - Return On Equity63.235619.5725159.51951398.168-87.0785-255.9402
Return On Tangible Equity63.235919.5725159.51971398.18-87.0784-255.94
ROA - Return On Assets18.5534-19.0764-129.537-98.5413-37.0011-74.6356
ROI - Return On Investment44.613446.5496291.7751-270.0583-60.8683-178.5584
Book Value Per Share0.9231-2.1527-3.445-0.25352.96093.9408
Operating Cash Flow Per Share1.7245-0.10522.6758-1.21217.10196.1981
Free Cash Flow Per Share1.7245-0.10522.6768-1.43199.75924.4798